Clinical trial
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced…
NCT00005965 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00005965 |
|---|---|
| Title | Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix |
| Official title | Phase II Clinical Trial of Bryostatin-1, NSC 339555, and Cisplatin in Patients With Recurrent and/or Advanced Inoperable Squamous Cell, Adeno or Adenosquamous Cell Carcinoma of the Cervix |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1, cisplatin |
| Start date | Aug 1, 2000 |
| Completion | Apr 1, 2004 |
| First posted | Mar 5, 2004 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: